Journal of Comprehensive Pediatrics

Published by: Kowsar

Factor XIII Deficiency, Review of the Literature and Report of a Case

Mojtaba Vahid Golpayegani 1 , Hossein Behnia 2 , Mahvareh Akhgar Araghi 3 and Ghassem Ansari 1 , *
Authors Information
1 Department of Pediatric Dentistry, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Oral & Maxillofacial Surgery, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Pedodontist, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: November 2016, 7 (4); e30303
  • Published Online: August 21, 2016
  • Article Type: Case Report
  • Received: June 14, 2015
  • Revised: July 24, 2016
  • Accepted: August 12, 2016
  • DOI: 10.17795/compreped-30303

To Cite: Vahid Golpayegani M, Behnia H, Akhgar Araghi M, Ansari G. Factor XIII Deficiency, Review of the Literature and Report of a Case, J Compr Ped. 2016 ; 7(4):e30303. doi: 10.17795/compreped-30303.

Abstract
Copyright © 2016, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnote
References
  • 1. Aeschlimann D, Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb Haemost. 1994; 71(4): 402-15[PubMed]
  • 2. Muszbek L, Adany R, Szegedi G, Polgar J, Kavai M. Factor XIII of blood coagulation in human monocytes. Thromb Res. 1985; 37(3): 401-10[PubMed]
  • 3. Sakata Y, Aoki N. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest. 1982; 69(3): 536-42[PubMed]
  • 4. Board PG, Losowsky MS, Miloszewski KJ. Factor XIII: inherited and acquired deficiency. Blood Rev. 1993; 7(4): 229-42[PubMed]
  • 5. Burrows RF, Ray JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv. 2000; 55(2): 103-8[PubMed]
  • 6. Anwar R, Miloszewski KJ. Factor XIII deficiency. Br J Haematol. 1999; 107(3): 468-84[PubMed]
  • 7. Anwar R, Minford A, Gallivan L, Trinh C, Markham AF. Delayed umbilical bleeding: A presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics. 2002; 109(2): 32
  • 8. Miloszewski KJA, Losowski MS. Fibrin stabilization and factor XIII deficiency. 1988; : 175-202
  • 9. Lorand AL, Losowski MS, Miloszewski KJ. Human factor XIII: Fibrin stabilizing factor. 1980;
  • 10. Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest. 1990; 29(3): 235-8[PubMed]
  • 11. Al-Sharif FZ, Aljurf MD, Al-Momen AM, Ajlan AM, Musa MO, Al-Nounou RM, et al. Clinical and laboratory features of congenital factor XIII deficiency. Saudi Med J. 2002; 23(5): 552-4[PubMed]
  • 12. Ragaz S, Kemp G, Furlan M, Beck EA. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII. Thromb Haemost. 1976; 36(3): 537-41[PubMed]
  • 13. Cotter KL, Miloszewski KJ, Wall J, Losowsky MS. Effect of pasteurization on the placental factor XIII concentrate. Br J Haematol. 1989; 73(4): 574-5[PubMed]
  • 14. Walls WD, Losowski MS. Congenital deficiency of fibrin-stabilizing factor. Coagulation . 1968; 1: 111-8
  • 15. Ichinose A, Souri M, Izumi T, Takahashi N. Molecular and genetic mechanisms of factor XIII A subunit deficiency. Semin Thromb Hemost. 2000; 26(1): 5-10[PubMed]
  • 16. Killick CJ, Barton CJ, Aslam S, Standen G. Prenatal diagnosis in factor XIII-A deficiency. Arch Dis Child Fetal Neonatal Ed. 1999; 80(3): 238-9[PubMed]
  • 17. Karges HE, Metzner HJ. Therapeutic factor XIII preparations and perspectives for recombinant factor XIII. Semin Thromb Hemost. 1996; 22(5): 427-36[DOI][PubMed]
  • 18. Safety of long-term prophylaxis in inherited Factor XIII deficiency. Factor XIII. Second International Conference. Marburg, Stuttgart, Germany: FK Schattauer Verlagsgesellschaft mbH. : 155-60
  • 19. Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, et al. Factor XIII deficiency in Iran: a comprehensive review of the literature. Semin Thromb Hemost. 2015; 41(3): 323-9[DOI][PubMed]
  • 20. Naderi M, Eshghi P, Cohan N, Miri-Moghaddam E, Yaghmaee M, Karimi M. Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran. Haemophilia. 2012; 18(5): 773-6[DOI][PubMed]
  • 21. Inbal A, Oldenburg J, Carcao M, Rosholm A, Tehranchi R, Nugent D. Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood. 2012; 119(22): 5111-7[DOI][PubMed]
  • 22. Fadoo Z, Merchant Q, Rehman KA. New developments in the management of congenital Factor XIII deficiency. J Blood Med. 2013; 4: 65-73[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments